Novartis, NHS England move forward with ‘landmark’ access deal for cholesterol drug Leqvio

Novartis, NHS England move forward with ‘landmark’ access deal for cholesterol drug Leqvio
esagonowsky
Tue, 08/31/2021 – 14:34